Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Roy

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Revue Medicale De La Suisse Romande|April 20, 2004
[The hidden aspects of success: "learn to write for one's colleagues"]Louise Roy
Canadian Journal of Kidney Health and Disease|December 23, 2015
Retrospective analysis of the predictive factors of renal function loss after uninephrectomy in patients with chronic kidney disease G3 to G5Dominique Dupuis, Georges Ouellet, Louise Roy
Blood Purification|June 9, 2012
Hemodiafiltration does not improve drug protein binding compared to conventional hemodialysis: an in vitro studyLouis-Philippe Laurin, Renée Lévesque, Louise Roy
British Journal of Clinical Pharmacology|December 21, 2002
Quinine pharmacokinetics in chronic haemodialysis patientsLouise Roy, Pierre Bannon, Jean-Pierre Villeneuve, et al.
Canadian Journal of Kidney Health and Disease|October 31, 2019
Acute Kidney Injury in Critically Ill Children and Subsequent Chronic Kidney DiseaseErin Hessey, Sylvie Perreault, Marc Dorais, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 21, 2013
Population pharmacokinetic and pharmacodynamic modeling of acetazolamide in peritoneal dialysis patients and healthy volunteersCorinne Seng Yue, Huu Hung Huynh, Catherine Raymond, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 27, 2002
Peritoneal and pericardial communication after cardiac surgery with delayed clinical manifestationsLynne Senécal, Jean-François Cailhier, Carl Chartrand-Lefebvre, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 5, 2010
Does concomitant administration of sevelamer and calcium carbonate modify the control of phosphatemia?Georges Ouellet, Héloïse Cardinal, Marjolaine Mailhot, et al.
Nephron Extra|May 8, 2014
Risk factors and timing of native kidney biopsy complicationsMarie-Christine Simard-Meilleur, Stéphan Troyanov, Louise Roy, et al.
Clinical Chemistry|November 25, 2003
Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidismPierre D'Amour, Jean-Hugues Brossard, Louise Rousseau, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Revue Medicale De La Suisse Romande|April 20, 2004
[The hidden aspects of success: "learn to write for one's colleagues"]Louise Roy
Canadian Journal of Kidney Health and Disease|December 23, 2015
Retrospective analysis of the predictive factors of renal function loss after uninephrectomy in patients with chronic kidney disease G3 to G5Dominique Dupuis, Georges Ouellet, Louise Roy
Blood Purification|June 9, 2012
Hemodiafiltration does not improve drug protein binding compared to conventional hemodialysis: an in vitro studyLouis-Philippe Laurin, Renée Lévesque, Louise Roy
British Journal of Clinical Pharmacology|December 21, 2002
Quinine pharmacokinetics in chronic haemodialysis patientsLouise Roy, Pierre Bannon, Jean-Pierre Villeneuve, et al.
Canadian Journal of Kidney Health and Disease|October 31, 2019
Acute Kidney Injury in Critically Ill Children and Subsequent Chronic Kidney DiseaseErin Hessey, Sylvie Perreault, Marc Dorais, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 21, 2013
Population pharmacokinetic and pharmacodynamic modeling of acetazolamide in peritoneal dialysis patients and healthy volunteersCorinne Seng Yue, Huu Hung Huynh, Catherine Raymond, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 27, 2002
Peritoneal and pericardial communication after cardiac surgery with delayed clinical manifestationsLynne Senécal, Jean-François Cailhier, Carl Chartrand-Lefebvre, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 5, 2010
Does concomitant administration of sevelamer and calcium carbonate modify the control of phosphatemia?Georges Ouellet, Héloïse Cardinal, Marjolaine Mailhot, et al.
Nephron Extra|May 8, 2014
Risk factors and timing of native kidney biopsy complicationsMarie-Christine Simard-Meilleur, Stéphan Troyanov, Louise Roy, et al.
Clinical Chemistry|November 25, 2003
Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidismPierre D'Amour, Jean-Hugues Brossard, Louise Rousseau, et al.
Pageof 4